The effect of micronization method on characterization and deposition profiles of different dry powder formulations of cefotaxime sodium

Journal of Drug Delivery Science and Technology

Volumn 16, Issue 5, 2006, Pages 363-368

  Najafabadi, A R ^a,b   Asgharian, R ^a   Tajerzadeh, H ^a   Gilani, K ^a   Vatanara, A ^a   Darabi, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cefotaxime sodium; Dry powder inhaler; Jet milling; Lactose; Particle engineering; Spray drying

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CEPHALOSPORIN; DRUG CARRIER; PENICILLINASE;

ARTICLE; DENSITOMETRY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; IN VITRO STUDY; INHALER; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 33749490835     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(06)50066-8     Document Type: Article

References (28)

1. ZENG X.M., MARTIN G.P., MARRIOTT C. - The controlled delivery of drugs to the lung. - International Journal of Pharmaceutics, 124, 149-164, 1995.
2. BYRON P.R.- Prediction of drug residence time, in region of the human respiratory tract following aerosol inhalation. Journal of Pharmaceutical Science, 75, 433-438, 1986.
3. BYRON P.R. - Some future perspectives for unit dose inhalation aerosols. - Drug Development Ind Pharm., 12, 993-1015, 1986.
4. BISGARD H. - Targeting drugs to the respiratory tract. - Res. Immunol., 149, 229-331, 1998.
5. DOLOVICH M. - Characterization of medical aerosols: physical and clinical requirements for new inhalers. - Aerosol Science and Technology, 22, 392-399, 1995.
6. KAWASHIMA Y., SERIGANO T., HINO T., YAMAMOTO H., TAKEUCHI H. - Effect of surface morphology of carrier lactose on dry powder inhalation property of pranlukast hydrate. - International Journal of Pharmaceutics, 172, 179-188, 1998.
7. GILANI K., ROUHOLAMINI NAJAFABADI A., DARABI M., BARGHI M., RAFIEE-TEHRANI M. - Influence of formulation variables and inhalation device on the deposition profiles of cromolyn sodium dry powder aerosols. - DARU, 12, 123-130, 2004.
8. GUPTA P.K., HICKEY A.J. - Contemporary approaches in aerosolized drug delivery to the lung. Journal of Control Release, 17, 127-147, 19991.
9. PRIME D., AKTINS P.J., SLATER A., SUMBY B. - Review of dry powder inhalers. - Advanced Drug Delivery Reviews, 26, 51-58, 1997.
10. GANDERTON D. - The generation of respirable clouds from coarse powder aggregates. - Journal of Biopharmaceutical Science, 3, 101-105, 1992.
11. MALCOLMSON R.J., EMBLETON J.K. - Dry powder formulations for pulmonary delivery. - Journal of Pharmaceutical Science Technology, 1, 394-398, 1998.
12. GUPTA P., BANSAL A.K. - Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine. Pharmaceutical Development and Technology, 10, 273-281, 2005.
13. CHAWLA A., TAYLOR K.M.G., NEWTON J.M., JOHNSON M.C.R. - Production of spray dried salbutamol sulphate for use in dry powder aerosol formulation. - International Journal of Pharmaceutics, 108, 233-240, 1994.
14. VIDGRÉN M.T., VIDGRÉN P.A., PARONEN T.P. - Comparison of physical and inhalation properties of spray-dried and mechanically micronized disodium cromoglycate. - International Journal of Pharmaceutics, 35, 139-144, 1987.
15. RASENACK N., STECKEL H., MÜLLER B.W. - Preparation of microcrystals by in situ micronization. - Powder Technology, 143-144, 291-296, 2004.
16. MONTGOMERY A.B. - Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections. - United States Patent Application, 20030055034, 2003.
17. LE BRUN P.P.H., DE BOER D., GJALTEMA A.H., HAGEDOORN P., HEIJERMAN H.G.M., FRIJLINK H.W. - Inhalation of tobramycin in cystic fibrosis Part 2: Optimization of tobramycin solution for a jet and ultrasonic nebulizer. - International Journal of Pharmaceutics, 189, 215-225, 1999.
18. DIOT P. DEQUIN P.F., RIVORE B., GAGNADOUX F., FAURISSON F., DIOT E., BOISSINOT E., LEPAPE A., PALMER L., LEMARIE E. - Aerosols and anti-infectious agents. - Journal of Aerosol Medicine, 14, 55-64, 2001.
19. LE BRUN P.P.H., DE BOER A.H., GJALTEMA D., HEIJERMAN H.G.M. - A review of the technical aspects of drug nebulization. - Pharm. World Sci., 22, 75-81, 2000.
20. DE BOER A.H., LE BRUN P.P.H., VAN DER WOUDE H.G., HAGEDOORN P., HEIJERMAN H.G.M., FRIJLINK H.W. - Dry powder inhalation of antibiotics in cystic fibrosis therapy. I. Development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle. - Eur. J. Pharm. Biopharm., 54, 17-24, 2002.
21. LE BRUN P.P.H., DE BOER A.H., MANNES G.P.M., DE FRAITURE D.M.I., BRIMICOMBE R.W., TOUW D.J., VINKS A.A., FRIJLINK H.W., HEIJERMAN H.G.M. - Dry powder inhalation of antibiotics in cystic fibrosis therapy. 2. Inhalation of novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients. - Eur. J. Pharm. Biopharm., 54, 25-32, 2002.
22. BRUCH H.P., KUJATH P. - Study of cefotaxime twice-daily for the therapy of postoperative pneumonia. - Diagn. Microbial Infect., 22, 203-207, 1995.
23. BOCCAZZI A., TONELLI P., BELLOSTA C., CAREDDU P. - Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections. - Diagn. Microbial Infect., 32, 265-272, 1998.
24. HICKEY A.J., CONCESSIO N.M., VAN OORT M.M., PLATZ P.M. - Factors influencing the dispersion of dry powders as aerosols. - Pharm. Technol., 8, 58-64, 1994.
25. STANIFORTH J.N., REES J.E., LAI F.K., HERSEYS J.A. - Determination of interparticulate forces in ordered powder mixes. - J. Pharm. Pharmacol., 33, 485-490, 1981.
26. VISSER J. - Van der Waals and other cohesive forces affecting powder fluidization. - Powder Technol., 58, 1-10, 1989.
27. STECKEL H., MULLER B.W. - In vitro evaluation of dry powder inhalers II: influence of carrier particle size and concentration on in vitro deposition. - International Journal of Pharmaceutics, 154, 31-37, 1997.
28. YOUNG P.M., EDGE S. TRAINI D., JONES M.D., PRICE R., EL-SABAWI D., URRY C., SMITH C. - The influence of dose on the performance of dry powder inhalation systems. - International Journal of Pharmaceutics, 296, 26-33, 2005.